Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
WorkcompWire
Article
Ripple Effect: Potential Impacts of Tariffs and Proposed Medicaid Cuts on Workers’ Comp
Workers' Comp
Article
Strengthening Return-to-Work Outcomes: A Guide to Vocational Case Management for Claims Professionals
When a workplace injury disrupts an employee’s ability to work, the path back to productivity can be complex.
Insurance Journal
Article
A True Alternative to Opioids for Workers’ Comp? Questions Remain
Enlyte’s Nikki Wilson weighs in on suzetrigine as a potential opioid alternative in workers’ comp.
Workers' Comp
Article
The Implications of Trump's Health Care Executive Order for Workers' Compensation and Auto Insurers
On April 15, 2025, President Donald Trump signed a significant health care executive order aimed at reducing health care costs and providing substa
WorkcompWire
In the News
Enlyte Releases 2025 Drug Trends Report, Part 1: Opioids Down, Migraine Meds Up
Workers' Comp
Article
Ask The Pharmacist: Bird Flu and Its Growing Impact on Public Health
How serious is the threat of bird flu in North America? Bird flu, or avian influenza, is an emerging public health and industry conce